Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karina-Doris Vihta

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Antimicrobial Chemotherapy|December 18, 2021
Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological studyShirin Aliabadi, Elita Jauneikaite, Berit Müller-Pebody, et al.
Emerging Infectious Diseases|September 7, 2023
Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022Rebecca E Harrison, Ahmed Hamada, Nujcharee Haswell, et al.
Communications Medicine|October 10, 2024
Predicting future hospital antimicrobial resistance prevalence using machine learningKarina-Doris Vihta, Emma Pritchard, Koen B Pouwels, et al.
The Journal of Infection|September 5, 2025
An Electronic Health Record-Wide Association Study to identify populations at increased risk of E. coli bloodstream infectionsEmma Pritchard, Karina-Doris Vihta, Samuel Lipworth, et al.
American Journal of Epidemiology|May 29, 2024
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplarEmma Pritchard, Karina-Doris Vihta, David W Eyre, et al.
Scientific Reports|December 8, 2023
Diversity of symptom phenotypes in SARS-CoV-2 community infections observed in multiple large datasetsMartyn Fyles, Karina-Doris Vihta, Carole H Sudre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2021
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United KingdomKarina Doris Vihta, Koen B Pouwels, Tim E A Peto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2022
Omicron-associated changes in SARS-CoV-2 symptoms in the United KingdomKarina Doris Vihta, Koen B Pouwels, Tim Ea Peto, et al.
Genome Medicine|September 4, 2021
Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UKSamuel Lipworth, Karina-Doris Vihta, Kevin Chau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2021
Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive InfectionsSamuel Lipworth, Karina-Doris Vihta, Kevin K Chau, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Antimicrobial Chemotherapy|December 18, 2021
Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological studyShirin Aliabadi, Elita Jauneikaite, Berit Müller-Pebody, et al.
Emerging Infectious Diseases|September 7, 2023
Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022Rebecca E Harrison, Ahmed Hamada, Nujcharee Haswell, et al.
Communications Medicine|October 10, 2024
Predicting future hospital antimicrobial resistance prevalence using machine learningKarina-Doris Vihta, Emma Pritchard, Koen B Pouwels, et al.
The Journal of Infection|September 5, 2025
An Electronic Health Record-Wide Association Study to identify populations at increased risk of E. coli bloodstream infectionsEmma Pritchard, Karina-Doris Vihta, Samuel Lipworth, et al.
American Journal of Epidemiology|May 29, 2024
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplarEmma Pritchard, Karina-Doris Vihta, David W Eyre, et al.
Scientific Reports|December 8, 2023
Diversity of symptom phenotypes in SARS-CoV-2 community infections observed in multiple large datasetsMartyn Fyles, Karina-Doris Vihta, Carole H Sudre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2021
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United KingdomKarina Doris Vihta, Koen B Pouwels, Tim E A Peto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2022
Omicron-associated changes in SARS-CoV-2 symptoms in the United KingdomKarina Doris Vihta, Koen B Pouwels, Tim Ea Peto, et al.
Genome Medicine|September 4, 2021
Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UKSamuel Lipworth, Karina-Doris Vihta, Kevin Chau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2021
Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive InfectionsSamuel Lipworth, Karina-Doris Vihta, Kevin K Chau, et al.
Pageof 3